Diet and BMI Correlate with Metabolite Patterns Associated with Aggressive Prostate Cancer.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
12 Aug 2022
Historique:
received: 19 07 2022
revised: 08 08 2022
accepted: 10 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 30 8 2022
Statut: epublish

Résumé

Three metabolite patterns have previously shown prospective inverse associations with the risk of aggressive prostate cancer within the European Prospective Investigation into Cancer and Nutrition (EPIC). Here, we investigated dietary and lifestyle correlates of these three prostate cancer-related metabolite patterns, which included: 64 phosphatidylcholines and three hydroxysphingomyelins (Pattern 1), acylcarnitines C18:1 and C18:2, glutamate, ornithine, and taurine (Pattern 2), and 8 lysophosphatidylcholines (Pattern 3). In a two-stage cross-sectional discovery (n = 2524) and validation (n = 518) design containing 3042 men free of cancer in EPIC, we estimated the associations of 24 dietary and lifestyle variables with each pattern and the contributing individual metabolites. Associations statistically significant after both correction for multiple testing (False Discovery Rate = 0.05) in the discovery set and at p < 0.05 in the validation set were considered robust. Intakes of alcohol, total fish products, and its subsets total fish and lean fish were positively associated with Pattern 1. Body mass index (BMI) was positively associated with Pattern 2, which appeared to be driven by a strong positive BMI-glutamate association. Finally, both BMI and fatty fish were inversely associated with Pattern 3. In conclusion, these results indicate associations of fish and its subtypes, alcohol, and BMI with metabolite patterns that are inversely associated with risk of aggressive prostate cancer.

Identifiants

pubmed: 36014812
pii: nu14163306
doi: 10.3390/nu14163306
pmc: PMC9415102
pii:
doi:

Substances chimiques

Glutamates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Cancer Research UK
ID : C8221/A30904
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8221/A29017
Pays : United Kingdom

Références

PLoS Med. 2021 Sep 20;18(9):e1003786
pubmed: 34543281
Cancer. 1989 Aug 1;64(3):598-604
pubmed: 2743254
Int J Epidemiol. 1997;26 Suppl 1:S1-5
pubmed: 9126528
Int J Epidemiol. 2001 Aug;30(4):749-55
pubmed: 11511598
Am J Clin Nutr. 2014 Jun;99(6):1286-308
pubmed: 24760973
Am J Epidemiol. 2011 May 15;173(10):1097-104
pubmed: 21474587
Epidemiology. 1994 May;5(3):276-82
pubmed: 8038241
Am J Epidemiol. 2004 Mar 1;159(5):444-53
pubmed: 14977640
Prostaglandins Leukot Essent Fatty Acids. 2014 Feb-Mar;90(2-3):61-8
pubmed: 24373610
Public Health Nutr. 2002 Dec;5(6B):1227-42
pubmed: 12639229
Metabolomics. 2009 Dec;5(4):435-458
pubmed: 20046865
Int J Cancer. 2020 Feb 1;146(3):720-730
pubmed: 30951192
Ann Epidemiol. 1999 May;9(4):254-61
pubmed: 10332931
Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1282-7
pubmed: 18483352
PLoS One. 2016 Jun 29;11(6):e0158568
pubmed: 27355821
Cancer Causes Control. 1999 Dec;10(6):597-605
pubmed: 10616828
J Nutr. 2017 Jul;147(7):1366-1373
pubmed: 28592517
Am J Clin Nutr. 2006 Oct;84(4):929-35
pubmed: 17023722
Nutrients. 2020 Sep 23;12(10):
pubmed: 32977480
BMC Med. 2021 Dec 10;19(1):312
pubmed: 34886862
Am J Clin Nutr. 2009 Sep;90(3):602-12
pubmed: 19491385
J Urol. 1996 Mar;155(3):969-74
pubmed: 8583620
Oncotarget. 2017 Jul 11;8(28):45190-45199
pubmed: 28423352
PLoS One. 2013 Sep 02;8(9):e72715
pubmed: 24023767
Cancer Res. 1989 Apr 1;49(7):1857-60
pubmed: 2924323
BMC Med. 2015 Sep 23;13:242
pubmed: 26399231
Cancer Causes Control. 1999 Aug;10(4):269-75
pubmed: 10482485
Circulation. 2012 May 8;125(18):2222-31
pubmed: 22496159
Cancer Causes Control. 2004 Nov;15(9):911-20
pubmed: 15577293
Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):64-7
pubmed: 12540506
Circ Cardiovasc Genet. 2016 Dec;9(6):487-494
pubmed: 27784734
Anal Chem. 2017 Jan 3;89(1):656-665
pubmed: 27959516
Lancet. 2001 Jun 2;357(9270):1764-6
pubmed: 11403817
Cancer Res. 1990 Nov 1;50(21):6836-40
pubmed: 2208150
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Eur J Clin Nutr. 2018 Jun;72(6):832-840
pubmed: 29849178
Int J Cancer. 2018 Feb 1;142(3):449-459
pubmed: 28688112
Eur J Clin Nutr. 2013 Oct;67(10):1100-8
pubmed: 23942179
J Clin Med. 2019 Feb 06;8(2):
pubmed: 30736371
Public Health Nutr. 2003 Jun;6(4):407-13
pubmed: 12795830
Metabolites. 2021 Sep 17;11(9):
pubmed: 34564446
J Proteome Res. 2017 Sep 1;16(9):3137-3146
pubmed: 28758405
Cancer Prev Res (Phila). 2011 Apr;4(4):486-501
pubmed: 21233290
Int J Cancer. 2016 Feb 15;138(4):853-65
pubmed: 26355806
Am J Epidemiol. 2007 Jun 1;165(11):1271-9
pubmed: 17395597
Transl Psychiatry. 2013 Jul 02;3:e276
pubmed: 23820610
Int J Cancer. 2006 Sep 15;119(6):1501-4
pubmed: 16615108
BMC Med. 2021 Apr 30;19(1):101
pubmed: 33926456
Nutr Cancer. 2006;56(1):50-6
pubmed: 17176217
Br J Cancer. 1999 Jun;80(7):1107-13
pubmed: 10362125
Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):63-9
pubmed: 17179486
Int J Cancer. 2016 Jan 15;138(2):348-60
pubmed: 26238458
BMC Med. 2020 Jul 23;18(1):187
pubmed: 32698845

Auteurs

Zoe S Grenville (ZS)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.

Urwah Noor (U)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.

Mathilde His (M)

Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.

Vivian Viallon (V)

Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.

Sabina Rinaldi (S)

Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.

Elom K Aglago (EK)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, UK.

Pilar Amiano (P)

Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, 20013 San Sebastian, Spain.
Biodonostia Health Research Institute, Epidemiology of Chronic and Communicable Diseases Group, 20014 San Sebastián, Spain.
Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Louise Brunkwall (L)

Department of Clinical Sciences, Lund University, 221 84 Malmö, Sweden.

María Dolores Chirlaque (MD)

CIBER of Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, 30008 Murcia, Spain.

Isabel Drake (I)

Department of Clinical Sciences, Lund University, 221 84 Malmö, Sweden.
Skåne University Hospital, 214 28 Malmö, Sweden.

Fabian Eichelmann (F)

Department of Molecular Epidemiology, German Institute of Human Nutrition, 14558 Nuthetal, Germany.

Heinz Freisling (H)

Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.

Sara Grioni (S)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Alicia K Heath (AK)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, UK.

Rudolf Kaaks (R)

Department of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Verena Katzke (V)

Department of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Ana-Lucia Mayén-Chacon (AL)

Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.

Lorenzo Milani (L)

Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, 10124 Turin, Italy.

Conchi Moreno-Iribas (C)

CIBER of Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Navarra Public Health Institute, 31003 Pamplona, Spain.
Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.

Valeria Pala (V)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Anja Olsen (A)

Danish Cancer Society Research Center, DK-2100 Copenhagen, Denmark.
Department of Public Health, Aarhus University, DK-8000 Aarhus, Denmark.

Maria-Jose Sánchez (MJ)

Escuela Andaluza de Salud Pública (EASP), 18011 Granada, Spain.
Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Granada, 18071 Granada, Spain.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition, 14558 Nuthetal, Germany.

Anne Tjønneland (A)

Danish Cancer Society Research Center, DK-2100 Copenhagen, Denmark.
Department of Public Health, University of Copenhagen, DK-1353 Copenhagen, Denmark.

Konstantinos K Tsilidis (KK)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, UK.
Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, 45110 Ioannina, Greece.

Elisabete Weiderpass (E)

International Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.

Anna Winkvist (A)

Sustainable Health, Department of Public Health and Clinical Medicine, Umeå University, 901 87 Umeå, Sweden.
Department of Internal Medicine and Clinical Nutrition, The Sahlgrenska Academy, University of Gothenburg, 413 45 Gothenburg, Sweden.

Raul Zamora-Ros (R)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.

Timothy J Key (TJ)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.

Karl Smith-Byrne (K)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.

Ruth C Travis (RC)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.

Julie A Schmidt (JA)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.
Department of Clinical Epidemiology, Department of Clinical Medicine, University Hospital, Aarhus University and Aarhus, DK-8200 Aarhus N, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH